Key facts
- Arterya’s last known valuation is $4.7M (Dec 2025).
- It has raised $2.0M; the latest was Angel (individual) ($230K) in Jan 2026.
- Notable investors include La Synapse, Normandie Incubation, Pépite.
- Status: Privately Held (backing).
Investors
3- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Arterya
- ·The full record, as it builds
Funding rounds
No funding rounds for Arterya are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Arterya
Developer of a medical device designed to detect pulsatility of the artery in patients. The company's device utilizes laser technology for the detection of arteries and the area to be sampled, allowing accurate, successful arterial blood sampling, enabling healthcare establishments to use equipment that is reusable and suitable for all skin and body types.
- Sector
- Healthcare
- HQ
- Herouville-Saint-Clair, France
- Founded
- 2020
- Employees
- 10
- Website
- arterya.com/
- Ownership
- Privately Held (backing)
Arterya doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Arterya shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Arterya in its N-PORT filings yet. We sweep new filings monthly.